Association between depressive symptoms and use of HMG-CoA reductase inhibitors (statins), corticosteroids and histamine H2 receptor antagonists in community-dwelling older persons: Cross-sectional analysis of a population-based cohort

Drugs and Aging

Volumn 25, Issue 9, 2008, Pages 795-805

  Feng, Liang ^a   Tan, Chay Hoon ^a   Merchant, Reshma A ^b   Ng, Tze Pin ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

Corticosteroids, therapeutic use; Depression; Elderly; Histamine H2 receptor antagonists, therapeutic use; HMG CoA reductase inhibitors, therapeutic use

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTIPARKINSON AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPNOTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; SEDATIVE AGENT; TRANQUILIZER;

ADULT; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; COMMUNITY CARE; DEPRESSION; DISEASE ASSOCIATION; DRUG USE; FEMALE; GERIATRIC DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR;

AGE FACTORS; AGED; AGED, 80 AND OVER; CLINICAL TRIALS AS TOPIC; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DEPRESSION; FEMALE; GLUCOCORTICOIDS; HISTAMINE H2 ANTAGONISTS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PSYCHIATRIC STATUS RATING SCALES; RISK FACTORS;

EID: 50249178514     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-200825090-00005     Document Type: Article

References (59)

1. Muldoon MF, Manuck SB, Matthews KA. Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials. BMJ 1990; 301: 309-14
2. Brown SL, Salive ME, Harris TB, et al. Low cholesterol concentrations and severe depressive symptoms in elderly people. BMJ 1994; 308: 1328-32
3. Lester D. Serum cholesterol levels and suicide: a meta-analysis. Suicide Life Threat Behav 2002; 32: 333-46
4. Golomb BA. Cholesterol and violence: is there a connection? Ann Intern Med 1998; 128: 478-87
5. Morgan RE, Palinkas LA, Barrett-Connor EL, et al. Plasma cholesterol and depressive symptoms in older men. Lancet 1993; 341: 75-9
6. Aijanseppa S, Kivinen P, Helkala EL, et al. Serum cholesterol and depressive symptoms in elderly Finnish men. Int J Geriatr Psychiatry 2002 Jul; 17 (7): 629-34
7. Engelberg H. Low serum cholesterol and suicide. Lancet 1992; 339: 727-9
8. Terao T, Nakamura J, Yoshimura R, et al. Relationship between serum cholesterol levels and metachlorophenylpiperazine-induced cortisol responses in healthy men and women. Psychiatry Res 2000; 96: 167-73
9. Vartiainen E, Puska P, Pekkanen J, et al. Serum cholesterol concentration and mortality from accidents, suicide, and other violent causes. BMJ 1994; 309: 445-7
10. Muldoon MF, Manuck SB, Mendelsohn AB, et al. Cholesterol reduction and non-illness mortality: meta-analysis of randomized clinical trials. BMJ 2001; 322: 11-5
11. Muldoon MF, Barger SD, Ryan CM, et al. Effects of lovastatin on cognitive function and psychological well-being. Am J Med 2000; 108: 538-46
12. Stewart RA, Sharpies KJ, North FM, et al. Long-term assessment of psychological well being in a randomized placebo-controlled trial of cholesterol reduction with pravastatin. Arch Intern Med 2000; 160: 3144-52
13. Yang CC, Jick SS, Jick H. Lipid lowering drugs and the risk of depression and suicidal behavior. Arch Intern Med 2003; 163: 1926-32
14. Ormiston T, Wolkowitz OM, Reus VI, et al. Behavioral implications of lowering cholesterol levels: a double-blind pilot-study. Psychosomatics 2003 Sep-Oct; 44 (5): 412-4
15. Dubrovsky B. Effects of adrenal cortex hormones on limbic structures: some experimental and clinical correlations related to depression. J Psychiatry Neurosci 1993 Jan; 18 (1): 4-16
16. Brown ES, Rush AJ, McEwen BS. Hippocampal remodeling and damage by corticosteroids: implications for mood disorders. Neuropsychopharmacology 1999 Oct; 21 (4): 474-84
17. Patten SB. Exogenous corticosteroids and major depression in the general population. J Psychosom Res 2000 Dec; 49 (6): 447-9
18. Patten SB, Williams JV, Love EJ. Self-reported depressive symptoms following treatment with corticosteroids and sedative-hypnotics. Int J Psychiatry Med 1996; 26 (1): 15-24
19. Patten SB, Williams JV, Love EJ. A case-control study of corticosteroid exposure as a risk factor for clinically-diagnosed depressive disorders in a hospitalized population. Can J Psychiatry 1995 Sep; 40 (7): 396-400
20. Billings RF, Tang SW, Rakoff VM. Depression associated with cimetidine. Can J Psychiatry 1981; 26: 260-1
21. Billings RF, Stein MB. Depression associated with ranitidine. Am J Psychiatry 1986; 143: 915-6
22. Dhondt TD, Beekman AT, Deeg DJ, et al. Iatrogenic depression in the elderly: results from a community-based study in the Netherlands. Soc Psychiatry Psychiatr Epidemiol 2002 Aug; 37 (8): 393-8
23. Patten SB, Williams JVA, Love EJ. H2-blocker exposure as a risk factor for depression. Can J Psychiatry 1996; 41: 537-8
24. Freis ED. Mental depressions in hypertensive patients treated for long periods with large doses of reserpine. N Engl J Med 1954; 251: 1006-8
25. Lemieux G, Davignon A, Genest J. Depressive states during Rauwolfia therapy for arterial hypertension: a report of 30 cases. Can Med Assoc 1956; 74: 522-6
26. Musselman DL, DeBattista C, Nathan KI, et al. Biology of mood disorders. In: Schatzberg AF, Nemeroff CB, editors. Textbook of psychopharmacology. 2nd ed. Washington, DC: American Psychiatric Press; 1998: 549-88
27. Prisant LM, Spruill WJ, Fincham JE, et al. Depression associated with antihypertensive drugs. J Fam Pract 1991; 33: 481-5
28. Wildmer RB. Reserpine: the maligned antihypertensive drug. J Fam Pract 1985; 20: 81-3
29. Patten SB, Barbui C. Drug-induced depression: a systematic review to inform clinical practice. Psychother Psychosom 2004; 73: 207-15
30. Kotlyar M, Dysken M, Adson DE. Update on drug-induced depression in the elderly. Am J Geriatr Pharmacother 2005 Dec; 3 (4): 288-300
31. Ng TP, Niti M, Chiam PC, et al. Prevalence and correlates of functional disability in multiethnic elderly Singaporeans. J Am Geriatr Soc 2006; 54 (1): 21-9
32. Yesavage J. Geriatric Depression Scale. Psychopharmacol Bull 1988; 24 (4): 709-11
33. Lim PP, Ng LL, Chiam PC, et al. Validation and comparison of three brief depression scales in an elderly Chinese population. Int J Geriatr Psychiatry 2000; 15: 824-30
34. Nyunt MSZ, Fones CSL, Niti M, et al. Criterion-based validity and reliability of the Geriatric Depression Screening Scale (GDS-15) in a large validation sample of community-living Asian older adults. Aging Ment Health. In press
35. Broekman BF, Nyunt SZ, Niti M, et al. Differential item functioning of the Geriatric Depression Scale in an Asian population. J Affect Disord 2008; 108 (3): 285-90
36. Norwegian Institute of Public Health. Guidelines for ATC classification and DDD assignment. 7th ed. Oslo: WHO Collaborating Centre for Drug Statistics Methodology, 2003
37. Patten SB, Love EJ. Can drugs cause depression? A review of the evidence. J Psychiatry Neurosci 1993 May; 18 (3): 92-102
38. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969; 9 (3): 179-86
39. Mahoney FI, Barthel DW. Functional evaluation: the Barthel Index. Md State Med J 1965; 14: 61-5
40. Folstein MF, Folstein SE, McHugh PR. Mini-mental state. J Psychiatr Res 1975; 12: 189-98
41. Ng TP, Niti M, Chiam PC, et al. Ethnic differences in cognitive performance on Mini-Mental State Examination in Asians. Am J Geriatr Psychiatry 2007; 15: 130-9
42. Niti MM, Ng TP, Kua EH, et al. Depression and chronic medical illnesses in Asian older adults: the role of subjective health and functional status. Int J Geriatr Psychiatry 2007; 22 (11): 1087-94
43. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 363 (9403): 157-63
44. Hosmer DW, Lemeshow S. Applied logistic regression. 2nd ed. New York, Singapore: John Wiley & Sons, 2000
45. Majani G, Pierobon A, Giardini A, et al. Relationship between psychological profile and cardiological variables in chronic heart failure. Eur Heart J 1999; 20: 1579-86
46. Havranek EP, Ware MG, Lowes BD. Prevalence of depression in congestive heart failure. Int J Psychiatry Med 1998; 28: 273-91
47. Frick MH, Elo O, Haapa K, et al. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med 1987 Nov 12; 317 (20): 1237-45
48. Bang LM, Goa KL. Pravastatin: a review of its use in elderly patients. Drugs Aging 2003; 20 (14): 1061-82
49. Vevera J, Fisar Z, Kvasnicka T, et al. Cholesterol-lowering therapy evokes time-limited changes in serotonergic transmission. Psychiatry Res 2005 Feb 28; 133 (2-3): 197-203
50. Glueck CJ, Tieger M, Kunkel R, et al. Improvement in symptoms of depression and in an index of life stressors accompanying treatment of severe hypertriglyceridemia. Biol Psychiatry 1993; 34: 240-52
51. McAlister FA, Lawson FM, Teo KK, et al. Randomised trials of secondary prevention programmes in coronary heart disease: systematic review. BMJ 2001 Oct 27; 323 (7319): 957-62
52. Nicholson AN, Stone BM. The H2-antagonists, cimetidine and ranitidine: studies on performance. Eur J Clin Pharmacol 1984; 26: 579-82
53. Levenstein S, Kaplan GA, Smith MW. Psychological predictors of peptic ulcer incidence in the Alameda County Study. J Clin Gastroenterol 1997; 24 (3): 140-6
54. Brown ES, Khan DA, Nejtek VA. The psychiatric side effects of corticosteroids. Allergy Asthma Immunol 1999; 83: 495-504
55. Wilkinson CW, Petrie EC, Murray SR, et al. Human glucocorticoid feedback inhibition is reduced in older individuals: evening study. J Clin Endocrinol Metab 2001; 86: 545-50
56. Hallas J. Evidence of depression provoked by cardiovascular medication: a prescription sequence symmetry analysis. Epidemiology 1996 Sep; 7 (5): 478-84
57. Patten SB, Williams JV, Love EJ. Case-control studies of cardiovascular medications as risk factors for clinically diagnosed depressive disorders in a hospitalized population. Can J Psychiatry 1996 Sep; 41 (7): 469-76
58. Neutel CI. A new, "user-friendly" terminology for confounding by indication in the study of adverse drug reactions. Post Market Surveill 1993; 7: 363-9
59. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed, text revision (DSM-IV-TR). Washington, DC: American Psychiatric Association, 2000